Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
Subvisible (2-100 μm) Particle Analysis During Biotherapeutic Drug Product Development: Part 1, Considerations and Strategy. [electronic resource] by
- Narhi, Linda O
- Corvari, Vincent
- Ripple, Dean C
- Afonina, Nataliya
- Cecchini, Irene
- Defelippis, Michael R
- Garidel, Patrick
- Herre, Andrea
- Koulov, Atanas V
- Lubiniecki, Tony
- Mahler, Hanns-Christian
- Mangiagalli, Paolo
- Nesta, Douglas
- Perez-Ramirez, Bernardo
- Polozova, Alla
- Rossi, Mara
- Schmidt, Roland
- Simler, Robert
- Singh, Satish
- Spitznagel, Thomas M
- Weiskopf, Andrew
- Wuchner, Klaus
Producer: 20160321
In:
Journal of pharmaceutical sciences vol. 104
Availability: No items available.
|
|
11.
|
Subvisible (2-100 μm) particle analysis during biotherapeutic drug product development: Part 2, experience with the application of subvisible particle analysis. [electronic resource] by
- Corvari, Vincent
- Narhi, Linda O
- Spitznagel, Thomas M
- Afonina, Nataliya
- Cao, Shawn
- Cash, Patricia
- Cecchini, Irene
- DeFelippis, Michael R
- Garidel, Patrick
- Herre, Andrea
- Koulov, Atanas V
- Lubiniecki, Tony
- Mahler, Hanns-Christian
- Mangiagalli, Paolo
- Nesta, Douglas
- Perez-Ramirez, Bernardo
- Polozova, Alla
- Rossi, Mara
- Schmidt, Roland
- Simler, Robert
- Singh, Satish
- Weiskopf, Andrew
- Wuchner, Klaus
Producer: 20160913
In:
Biologicals : journal of the International Association of Biological Standardization vol. 43
Availability: No items available.
|